AMBP
Ardagh Metal Packaging S.A.
AMBP offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN
Amazon.com, Inc.
AMZN has the edge over AMBP overall, supported by stronger valuation and stronger modeled upside.
AMBP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Weak |
AMBP's revenue and profitability are currently healthy, and its cash flow is stable, but its balance sheet is weak.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
AMBP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $0.95 | -79% |
| Forward | 17x | $4.61 | — |
| Fair | 41x | $3.71 | -19% |
| Current | 53x | $4.61 | — |
| Expensive | 88x | $7.92 | +72% |
Historical ranges are pointers, not guarantees.
AMBP's PE is in its expensive range at 53x. If earnings grow as analysts expect, today's price would be 17x next year's earnings, in its fair range.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over AMBP in the historical PE scenario, which offers more potential upside but is not a forecast.
AMBP Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for AMBP, with profitability holding steady. However, they disagree widely on these estimates.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
AMBP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.28 | +208% |
| Q3 2026 | $0.09 | +$0.11 |
| Q2 2026 | $0.05 | +$0.08 |
| Q1 2026 | -$0.01 | +$0.03 |
| Q4 2025 | -$0.02 | +$0.02 |
| Q3 2025 | -$0.02 | +$0.09 |
| Q2 2025 | -$0.03 | +$0.07 |
| Q1 2025 | -$0.04 | +$0.07 |
| Q4 2024 | -$0.04 | +$0.07 |
AMBP has returned to profit: it earned $0.09 per share over the past year, after losing money the year before.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN's earnings per share have climbed steadily: $12.37 over the past year, up 75% from the year before, and higher year over year for 14 quarters in a row. Its recent earnings include one-off gains.
AMBP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +19% |
| Q2 2026 | $1.7B | +18% |
| Q1 2026 | $1.5B | +19% |
| Q4 2025 | $1.3B | +13% |
| Q3 2025 | $1.4B | +8.8% |
| Q2 2025 | $1.5B | +16% |
| Q1 2025 | $1.3B | +11% |
| Q4 2024 | $1.2B | +5.6% |
AMBP has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.7% | +0.5 points |
| Q2 2026 | 6.7% | +0.8 points |
| Q1 2026 | 3.7% | +0.5 points |
| Q4 2025 | 2.5% | -1.6 points |
| Q3 2025 | 6.2% | -0.1 points |
| Q2 2025 | 5.9% | +1.5 points |
| Q1 2025 | 3.2% | +2 points |
| Q4 2024 | 4.2% | +5 points |
AMBP's operating margin was 6.7% last quarter, up 0.5 points from the same quarter a year ago.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over AMBP on profitability, with a higher operating margin.
AMBP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $136M | +3.8% |
| Q2 2026 | $256M | +52% |
| Q1 2026 | -$405M | -$56M |
| Q4 2025 | $315M | -7.1% |
| Q3 2025 | $131M | +3.1% |
| Q2 2025 | $168M | -15% |
| Q1 2025 | -$349M | +$51M |
| Q4 2024 | $339M | -6.9% |
AMBP has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
AMBP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | 0% | +100K shares |
| 5 years | +6.2% | +34.9M shares |
| Available history | +21% | +104M shares |
AMBP has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $289M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
AMBP spent $289M buying back its own shares over the past year, after none the year before.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
AMBP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.8x | High |
| Q2 2026 | 5.9x | High |
| Q1 2026 | 6.5x | High |
| Q4 2025 | 6.0x | High |
| Q3 2025 | 5.5x | High |
| Q2 2025 | 5.7x | High |
| Q1 2025 | 5.8x | High |
| Q4 2024 | 5.3x | High |
AMBP's net debt is about 5.8 years of its operating earnings (EBITDA), up from 5.5 years a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over AMBP on leverage, with a lower net debt burden relative to earnings.
AMBP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.8 | Neutral |
| Stochastic | 30.6 | Neutral |
AMBP's weekly RSI is 51 (neutral) and its Stochastic is 31 (neutral).
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
AMBP PE vs Consumer Cyclical Sector
| Metric | AMBP | Sector median | Relative |
|---|---|---|---|
| PE | 53x | 18x | 196% above |
| PE % | 73 | 55 | 18 pts above |
AMBP is trading at 53x earnings, a 196% premium to the Consumer Cyclical sector's median of 18x.
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over AMBP on valuation relative to its sector.
AMBP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.54 | 1.5% above |
| 20 week MA | $4.76 | 3.2% below |
| 50 week MA | $4.44 | 3.8% above |
| 100 week MA | $3.97 | 16% above |
| 200 week MA | $3.86 | 19% above |
AMBP's trend is mixed: it's above four of its five weekly moving averages, and 19% above its 200-week average.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over AMBP on trend strength, trading above more of its moving averages.
AMBP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $9.99 | $8.89 | -11% |
| 2022 | $8.89 | $4.75 | -47% |
| 2023 | $4.75 | $3.84 | -19% |
| 2024 | $3.84 | $3.02 | -21% |
| 2025 | $3.02 | $4.06 | +34% |
| 2026 YTD | $4.06 | $4.61 | +14% |
AMBP has finished lower in four of the last five years. It's up 14% so far in 2026.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over AMBP on returns for 2026, with the stronger performance.